Status:
COMPLETED
Real World Study of Bone Metastases in Patients with Advanced Breast Cancer
Lead Sponsor:
Zhejiang Cancer Hospital
Conditions:
Breast Cancer Metastatic
Eligibility:
All Genders
18+ years
Brief Summary
By analyzing the clinical data of patients with advanced breast cancer with bone metastasis admitted to our center from January 1, 2021 to February 28, 2023, this study aims to understand the real-wor...
Detailed Description
The specific contents of our research include the basic information of breast cancer patients with bone metastasis in the early stage, neoadjuvant therapy, surgery and postoperative pathology, and adj...
Eligibility Criteria
Inclusion
- Age ≥18y;
- Advanced breast cancer is clearly diagnosed;
- Imaging or pathology confirmed at least 1 bone metastasis;
- No history of other malignant tumors at the time of initial diagnosis;
- The physical status score of Eastern Tumor Collaboration Group (ECOG) was ≤2 points;
- Complete clinical and follow-up data.
Exclusion
- Exclusion is defined as meeting 1 of the following exclusion criteria:
- Patients with other malignant tumors;
- History of hyperthyroidism and hypothyroidism, abnormal parathyroid function;
- History of bone metabolic diseases.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
737 Patients enrolled
Trial Details
Trial ID
NCT06873997
Start Date
January 1 2021
End Date
December 1 2024
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang Cancer Hospital
Zhejiang, China